5th Oligonucleotide Analytical Development & CMC Summit 2026

 

Taking place in Boston, August 17–19, 2026, the 5th Oligonucleotide Analytical Development & CMC Summit is the premier forum for advancing oligonucleotide therapeutics development.

Featuring leaders from Alnylam, Biogen, Ionis Pharmaceuticals, Amgen, and Avidity Biosciences, the event addresses key challenges in analytical complexity, impurity control, and CMC strategy.

Participants will explore cutting-edge analytical techniques, evolving regulatory expectations, and scalable approaches for ASOs, siRNA, and conjugates.

With opportunities to network with 90+ industry experts, attendees will gain practical insights to enhance product quality, comparability, and regulatory readiness and accelerate programs toward successful commercialization.

More Info

---

---